Cumberland Pharmaceuticals Ownership | Who Owns Cumberland Pharmaceuticals?


OverviewForecastRevenueFinancialsChartTranscripts

Cumberland Pharmaceuticals Ownership Summary


Cumberland Pharmaceuticals is owned by 13.11% institutional investors, 44.15% insiders, and 42.74% retail investors. Renaissance is the largest institutional shareholder, holding 3.61% of CPIX shares. Vanguard US Total Market Shares ETF is the top mutual fund, with 2.01% of its assets in Cumberland Pharmaceuticals shares.

CPIX Ownership Benchmark


TypeName% Inst% Insiders% Retail
StockCumberland Pharmaceuticals13.11%44.15%42.74%
SectorHealthcare Stocks 57.39%9.93%32.68%
IndustrySpecialty & Generic Drug Manufacturers Stocks26.69%10.91%62.39%

Institutional Shareholders


Top Institutional Shareholders by Total Shares

HolderShares% HoldingValue
Renaissance507.16K3.61%$1.20M
Vanguard group374.25K2.66%$886.98K
Dimensional fund advisors lp272.97K1.94%$646.94K
Acadian asset management188.16K1.34%$444.00K
Bridgeway capital management184.16K1.31%$436.45K
Blackrock110.56K0.78%$169.16K
Bank of new york mellon75.27K0.54%$178.39K
Geode capital management74.31K0.53%$176.14K
Blackrock funding, inc. /de42.58K0.30%$100.92K
Two sigma investments, lp37.65K0.27%$89.23K

Top Institutional Shareholders by % of Total Assets

HolderShares% AssetsValue
Bridgeway capital management184.16K0.01%$436.45K
Renaissance507.16K0.00%$1.20M
Acadian asset management188.16K0.00%$444.00K
Cresset asset management22.27K0.00%$52.79K
Dimensional fund advisors lp272.97K0.00%$646.94K
Two sigma investments, lp37.65K0.00%$89.23K
Capital advisors437.000.00%$1.00K
Tower research capital llc (trc)2.22K0.00%$5.26K
Bank of america corp /de/67.00-$103.00
Advisor group---

Top Buyers

HolderShares% AssetsChange
Two sigma investments, lp37.65K0.00%18.27K
Cresset asset management22.27K0.00%1.00K
Capital advisors437.000.00%437.00
Bank of america corp /de/67.00-67.00
Bank of new york mellon75.27K-1.00

Top Sellers

HolderShares% AssetsChange
Bridgeway capital management184.16K0.01%-102.50K
Blackrock funding, inc. /de42.58K--67.49K
Two sigma advisers, lp---23.00K
Renaissance507.16K0.00%-21.00K
Dimensional fund advisors lp272.97K0.00%-11.04K

New Positions

HolderShares% AssetsChangeValue
Capital advisors437.000.00%437.00$1.00K

Sold Out

HolderChange
Advisor group-100.00
Innealta capital-948.00
Oakworth capital-3.05K
Schonfeld strategic advisors-10.00K
Two sigma advisers, lp-23.00K

Institutional Ownership Trends


DateHoldingsChange %SharesChange %OwnershipChange %Increased PositionChange %Decreased PositionChange %
Dec 31, 202421-8.70%1,842,038-9.87%136.20%4-55.56%10150.00%
Sep 30, 202423-4.17%2,043,812-1.62%146.70%950.00%4-20.00%
Jun 30, 202424-2,077,457-3.95%146.44%620.00%5-44.44%
Mar 31, 202424-4.00%2,162,869-1.58%156.39%5-37.50%950.00%
Dec 31, 20232513.64%2,197,513-0.47%156.54%860.00%6-

Top Mutual Funds Shareholders


HolderShares% HoldingChange
Vanguard US Total Market Shares ETF280.82K2.01%-
Vanguard Total Stock Mkt Idx Inv280.82K2.01%-
Bridgeway Ultra-Small Company133.07K0.95%-100.00K
Vanguard Institutional Extnd Mkt Idx Tr105.98K0.76%21.74K
DFA US Targeted Value I63.30K0.45%-16.42K
Bridgeway Ultra-Small Company Market49.89K0.36%-
DFA US Micro Cap I47.77K0.34%-
Fidelity Extended Market Index39.30K0.28%-250.00
Dimensional US Targeted Value ETF39.28K0.28%-
Dimensional US Small Cap ETF18.70K0.13%-

Recent Insider Transactions


DateNameRoleActivityValue
Mar 27, 2025Young Caroline-Buy$16.80
Mar 26, 2025Young Caroline-Buy$17.64
Mar 31, 2025Young Caroline-Buy$17.16
Mar 28, 2025Young Caroline-Buy$16.80
Mar 25, 2025Young Caroline-Buy$17.80

Insider Transactions Trends


DateBuySell
2026 Q1--
2025 Q1--
2024 Q3--
2024 Q2--
2024 Q1--

CPIX Ownership FAQ


Who Owns Cumberland Pharmaceuticals?

Cumberland Pharmaceuticals shareholders are primarily institutional investors at 13.11%, followed by 44.15% insiders and 42.74% retail investors. The average institutional ownership in Cumberland Pharmaceuticals's industry, Specialty & Generic Drug Manufacturers Stocks, is 26.69%, which Cumberland Pharmaceuticals falls below.

Who owns the most shares of Cumberland Pharmaceuticals?

Cumberland Pharmaceuticals’s largest shareholders are Renaissance (507.16K shares, 3.61%), Vanguard group (374.25K shares, 2.66%), and Dimensional fund advisors lp (272.97K shares, 1.94%). Together, they hold 8.21% of Cumberland Pharmaceuticals’s total shares outstanding.

Does Blackrock own Cumberland Pharmaceuticals?

Yes, BlackRock owns 0.78% of Cumberland Pharmaceuticals, totaling 110.56K shares as of Jun 2024. This represents 0% of BlackRock's total assets, with a market value of 169.16K$. In the last quarter, BlackRock decreased its holdings by 0 shares, a 0% change.

Who is Cumberland Pharmaceuticals’s biggest shareholder by percentage of total assets invested?

Bridgeway capital management is Cumberland Pharmaceuticals’s biggest shareholder by percentage of total assets invested, with 0.01% of its assets in 184.16K Cumberland Pharmaceuticals shares, valued at 436.45K$.

Who is the top mutual fund holder of Cumberland Pharmaceuticals shares?

Vanguard US Total Market Shares ETF is the top mutual fund holder of Cumberland Pharmaceuticals shares, with 2.01% of its total shares outstanding invested in 280.82K Cumberland Pharmaceuticals shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

  • Customize your own personal stocks lists, views and charts

  • Choose from hundreds of fields, up to 15 years of history

  • Conduct deep comparison analysis

  • Discover trending investment themes

  • Find your next best investment

  • Research stocks using tools